Simon, J H <br/><br/>
A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research Group.  [electronic resource] 

 -  Neurology  Jul 2000 
 - 185-92 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0028-3878 
<br/><br/><label>Standard No.: </label>10.1212/wnl.55.2.185  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--adverse effects<br/>Adult<br/>Brain--drug effects<br/>Disease Progression<br/>Female<br/>Humans<br/>Injections, Intramuscular<br/>Interferon beta-1a<br/>Interferon-beta--adverse effects<br/>Longitudinal Studies<br/>Magnetic Resonance Imaging<br/>Male<br/>Multiple Sclerosis, Relapsing-Remitting--diagnosis